795 related articles for article (PubMed ID: 31153385)
21. Dermatomyositis Identified During Palliative Care Management for Chemotherapy-Associated Pain: A Case Report.
Hamada H; Tanoue T; Saito O; Endo M; Miyazaki K; Miyasato A; Iketani S; Sugimori A; Watanabe C; Uchino H
J Palliat Care; 2022 Apr; 37(2):83-86. PubMed ID: 34823395
[No Abstract] [Full Text] [Related]
22. Asymptomatic Myocarditis with Mild Cardiac Marker Elevation Following Nivolumab-Induced Myositis.
Shindo A; Yamasaki M; Uchino K; Yamasaki M
Int Heart J; 2022; 63(1):180-183. PubMed ID: 35095069
[TBL] [Abstract][Full Text] [Related]
23. Successful treatment of refractory rash in paraneoplastic amyopathic dermatomyositis.
Aslanidis S; Pyrpasopoulou A; Kartali N; Zamboulis C
Clin Rheumatol; 2007 Jul; 26(7):1198-200. PubMed ID: 16779504
[TBL] [Abstract][Full Text] [Related]
24. Immune checkpoint-mediated myositis and myasthenia gravis: A case report and review of evaluation and management.
Kang KH; Grubb W; Sawlani K; Gibson MK; Hoimes CJ; Rogers LR; Lavertu P; Yao M
Am J Otolaryngol; 2018; 39(5):642-645. PubMed ID: 29903623
[TBL] [Abstract][Full Text] [Related]
25. [An autopsy case of nivolumab-induced myasthenia gravis and myositis].
Sawai T; Hosokawa T; Shigekiyo T; Ogawa S; Sano E; Arawaka S
Rinsho Shinkeigaku; 2019 Jun; 59(6):360-364. PubMed ID: 31142711
[TBL] [Abstract][Full Text] [Related]
26. Role of IVIG in the Treatment of Autoimmune Conditions With Concurrent Immune Checkpoint Inhibitors for Metastatic Cancer.
Punekar SR; Castillo R; Sandigursky S; Cho DC
J Immunother; 2021 Oct; 44(8):335-337. PubMed ID: 34166301
[TBL] [Abstract][Full Text] [Related]
27. Immune Checkpoint Inhibitor-Induced Myositis: a Case Report and Literature Review.
Kadota H; Gono T; Shirai Y; Okazaki Y; Takeno M; Kuwana M
Curr Rheumatol Rep; 2019 Feb; 21(4):10. PubMed ID: 30790071
[TBL] [Abstract][Full Text] [Related]
28. Rapidly progressive myositis as the sole manifestation of a concurrent gastric carcinoma.
Asadi M; Javanbakht M; Khajavian S; Zand S
BMJ Case Rep; 2010 Nov; 2010():. PubMed ID: 22791857
[TBL] [Abstract][Full Text] [Related]
29. Nivolumab and Ipilimumab-induced myositis and myocarditis mimicking a myasthenia gravis presentation.
Valenti-Azcarate R; Esparragosa Vazquez I; Toledano Illan C; Idoate Gastearena MA; Gállego Pérez-Larraya J
Neuromuscul Disord; 2020 Jan; 30(1):67-69. PubMed ID: 31839404
[TBL] [Abstract][Full Text] [Related]
30. A potential mechanism of the onset of acute eosinophilic pneumonia triggered by an anti-PD-1 immune checkpoint antibody in a lung cancer patient.
Jodai T; Yoshida C; Sato R; Kakiuchi Y; Sato N; Iyama S; Kimura T; Saruwatari K; Saeki S; Ichiyasu H; Fujii K; Tomita Y
Immun Inflamm Dis; 2019 Mar; 7(1):3-6. PubMed ID: 30461210
[TBL] [Abstract][Full Text] [Related]
31. Nivolumab-induced synchronous occurrence of myositis and hypothyroidism in a patient with squamous cell lung cancer.
Badovinac S; Korsic M; Zarkovic K; Mursic D; Roglic M; Jakopovic M; Samarzija M
Immunotherapy; 2018 Mar; 10(6):427-431. PubMed ID: 29562858
[TBL] [Abstract][Full Text] [Related]
32. Isolated adrenocorticotropic hormone deficiency and thyroiditis associated with nivolumab therapy in a patient with advanced lung adenocarcinoma: a case report and review of the literature.
Ohara N; Kobayashi M; Ohashi K; Ito R; Ikeda Y; Kawaguchi G; Yoneoka Y; Hasegawa G; Takada T
J Med Case Rep; 2019 Mar; 13(1):88. PubMed ID: 30909965
[TBL] [Abstract][Full Text] [Related]
33. [Dermatomyositis associated with metastatic rectal adenocarcinoma: case report].
Vesić S; Daković Z; Vukićević J; Vuković J; Stojković J; Medenica L
Med Pregl; 2009; 62(9-10):473-5. PubMed ID: 20391745
[TBL] [Abstract][Full Text] [Related]
34. Bicytopenia in Primary Lung Melanoma Treated with Nivolumab.
Takahashi A; Kubo A; Mizuno S; Kasai K; Asai N; Yonezawa T; Kosaka K; Nishimura M; Tanaka H; Yokoe N; Tsuzuki T; Takami A; Yamaguchi E
Intern Med; 2019 Mar; 58(6):827-831. PubMed ID: 30449777
[TBL] [Abstract][Full Text] [Related]
35. Dermatomyositis Induced by Hepatitis B Virus-related Hepatocellular Carcinoma: A Case Report and Review of the Literature.
Chou JW; Lin YL; Cheng KS; Wu PY; Reanne Ju T
Intern Med; 2017; 56(14):1831-1837. PubMed ID: 28717078
[TBL] [Abstract][Full Text] [Related]
36. Nivolumab-related myasthenia gravis with myositis requiring prolonged mechanical ventilation: a case report.
Saishu Y; Yoshida T; Seino Y; Nomura T
J Med Case Rep; 2022 Feb; 16(1):61. PubMed ID: 35152911
[TBL] [Abstract][Full Text] [Related]
37. Pembrolizumab-related systemic myositis involving ocular and hindneck muscles resembling myasthenic gravis: a case report.
Kamo H; Hatano T; Kanai K; Aoki N; Kamiyama D; Yokoyama K; Takanashi M; Yamashita Y; Shimo Y; Hattori N
BMC Neurol; 2019 Aug; 19(1):184. PubMed ID: 31382909
[TBL] [Abstract][Full Text] [Related]
38. Nivolumab-induced IgA nephropathy in a patient with advanced gastric cancer: A case report.
Tanabe K; Kanzaki H; Wada T; Nakashima Y; Sugiyama H; Okada H; Wada J
Medicine (Baltimore); 2020 May; 99(21):e20464. PubMed ID: 32481351
[TBL] [Abstract][Full Text] [Related]
39. Combination therapy of ipilimumab and nivolumab induced thyroid storm in a patient with Hashimoto's disease and diabetes mellitus: a case report.
Yonezaki K; Kobayashi T; Imachi H; Yoshimoto T; Kikuchi F; Fukunaga K; Sato S; Ibata T; Yamaji N; Lyu J; Dong T; Murao K
J Med Case Rep; 2018 Jun; 12(1):171. PubMed ID: 29914537
[TBL] [Abstract][Full Text] [Related]
40. Myositis and myasthenia during nivolumab administration for advanced lung cancer: a case report and review of the literature.
Veccia A; Kinspergher S; Grego E; Peterlana D; Berti A; Tranquillini E; Caffo O
Anticancer Drugs; 2020 Jun; 31(5):540-544. PubMed ID: 32011360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
